Popular on TelAve
- Human Resources Strategy Forum Celebrates 30 Years Empowering Leaders, Shaping the Next Generation of HR Innovators - 134
- Voices Rising Festival Celebrates Diversity in E. Islip, GRAMMY Governor LACHI performs!
- Allegiant Management Group Launches New Website Following Recent Rebranding
- Dr. Stephen Shainbart, PHD, Highlights 5 Reasons to Discuss Family Therapy and Couples Counseling in Buffalo, NY
- Leading Arizona Real Estate Team Rebrands to SPACE, Marking a New Era in Real Estate Innovation
- Origination of Prince Oak's new alias and reasons of his change — the Eurasian Prince's newest nominal label is "Papa Eurasia"
- AuthuSign Launches Mobile Web App, Empowering Users to Sign Documents on the Go
- Use Bitcoin to Earn Bitcoin - Innovative Layer 2 Solution for Bitcoin
- L-Strategies LLC terminates Angie Wong Miami Republican Committeewoman's contract with New Federal State of China NFSC
- Wagoner Roofing Launches New Website
Similar on TelAve
- Natural Sweetener Health Trend on the Rise: Black Friday Special Discounts Are Here!
- "House of War" Live Event & Podcast Series by Daniel Sadan Debuts This Week
- Terror Strikes - not if, but when, and Fight? Flight? Third option
- Riggo Production Studio Delivers Film and Video Production to U.S. Army Central
- U.S. Beauty and Personal Care Market Booming with Rising Demand for Natural and Organic Products
- CCHR Backs UN & Senate Calls for DOJ Action on Coercive Psychiatric Practices
- Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader: Heartbeam: Stock Symbol: BEAT
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Powerful Leadership Transition to Optimize Highly Promising AI Platform RenovaroCube for Multi-Cancer Early Detection & Monitoring: Stock Symbol: RENB
- Vantiva and Ann Mason Care Launch Innovative Remote-Enabled Home Care Service in the UK powered by the HomeSightTM Connected Care Solution
NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease Treatment
TelAve News/10838813
EXCELSIOR, Minn. - TelAve -- NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced today a partnership with prominent neuroscience venture builder and fund, Corundum Neuroscience. As part of the collaboration, Corundum will provide resources, including the initial investment in a NeuraWorx seed funding round, aimed at advancing product development and initiating a clinical feasibility study to explore the efficacy and safety of its Cerebrovascular Pacing SystemTM novel technology.
"Corundum Neuroscience exists to solve significant brain health challenges by discovering, funding and supporting companies building breakthrough technologies in neuroscience," said Liron Nunez Weissman, CEO of Corundum Neuroscience. "We see a significant market opportunity for NeuraWorx's technology and believe in its potential to revolutionize the treatments of neurological diseases and improve human health and lifespan."
NeuraWorx is developing the Cerebrovascular Pacing System, a first-in-class wearable neurostimulator, which leverages established bioelectronic principles to enhance the brain's glymphatic and cerebrovascular systems, aiming to enhance waste clearance for improved brain health.
"Approaches that modulate the brain's environment are creating new opportunities for improved brain function and we believe that NeuraWorx has a unique solution that could unlock this potential," said Josh Schulman, PhD, chief scientist of Corundum Neuroscience. "We're thrilled to partner with them on this study that aims to explore how their stimulation can impact the brain in ways that could lead to new treatments for brain injuries and diseases, as well as potentially impacting neurodegeneration in a range of brain states."
More on TelAve News
As a long-term partner, Corundum Neuroscience will support NeuraWorx as it continues to develop the Cerebrovascular Pacing System by providing access to Corundum Neuroscience's advanced technological projects, scientific expertise and strategic funding.
The upcoming clinical study will be a crucial step in understanding the potential of NeuraWorx's Cerebrovascular Pacing product, paving the way for future advancements in the treatment of central nervous system (CNS) disorders. Both companies are committed to pushing the boundaries of neuroscience to deliver life-changing solutions to improve the lives of patients worldwide. NeuraWorx intends to pursue indications for traumatic brain injury (TBI), Alzheimer's dementia and other CNS disorders, while also developing preventive solutions tailored for military personnel, athletes and a variety of medical applications.
"We are excited to work with Corundum Neuroscience, whose expertise and resources in the neuroscience field will be instrumental in advancing our technology," said Dr. Kip Ludwig, co-founder of NeuraWorx, associate professor at the University of Wisconsin-Madison and co-director of the Wisconsin Institute for Translational Neuroengineering.
"This partnership aligns perfectly with our mission to alleviate suffering and enhance quality of life by developing groundbreaking treatments and preventive solutions for CNS disorders," added Chris Minar, CEO at NeuraWorx.
For more information about NeuraWorx Medical Technologies, Inc., and its innovative approach, visit www.neuraworx.com. To learn more about Corundum Neuroscience and its initiatives, visit www.cnsfund.com.
About NeuraWorx
NeuraWorx Medical Technologies, Inc., is developing a Cerebrovascular Pacing SystemTM, as a first-in-class bioelectronic solution for enhancing cerebral spinal fluid flow and blood flow in the brain. Its products are intended to be for both preventative and therapeutic use, for traumatic brain injury (TBI), Alzheimer's dementia, and other CNS diseases. NeuraWorx was founded in Minnesota, shortly after its science was developed at the University of Wisconsin and the Mayo Clinic. For company updates and information, follow NeuraWorx on LinkedIn or visit: https://www.neuraworx.com
More on TelAve News
About Corundum Neuroscience
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity, and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023 and is headquartered in Herzliya, Israel.
For company updates and information, follow Corundum Neuroscience on LinkedIn or visit https://cnsfund.com.
"Corundum Neuroscience exists to solve significant brain health challenges by discovering, funding and supporting companies building breakthrough technologies in neuroscience," said Liron Nunez Weissman, CEO of Corundum Neuroscience. "We see a significant market opportunity for NeuraWorx's technology and believe in its potential to revolutionize the treatments of neurological diseases and improve human health and lifespan."
NeuraWorx is developing the Cerebrovascular Pacing System, a first-in-class wearable neurostimulator, which leverages established bioelectronic principles to enhance the brain's glymphatic and cerebrovascular systems, aiming to enhance waste clearance for improved brain health.
"Approaches that modulate the brain's environment are creating new opportunities for improved brain function and we believe that NeuraWorx has a unique solution that could unlock this potential," said Josh Schulman, PhD, chief scientist of Corundum Neuroscience. "We're thrilled to partner with them on this study that aims to explore how their stimulation can impact the brain in ways that could lead to new treatments for brain injuries and diseases, as well as potentially impacting neurodegeneration in a range of brain states."
More on TelAve News
- OpsVeda Announces General Availability Of Release 10.0 Of Its AI Powered Operations Command Center
- Celebrate Christmas 2024 with Exclusive Deals and Festive Offers
- Klatt Works, Executive Flightways, L2 Aviation, and Ametek Revolutionize Business Jet Safety with the First SAVED System STC for the G550
- Bainbridge Custom Builders Launches to Redefine Custom Construction and Renovation in Philadelphia
- 76 FENCE Expands in North Carolina with Strategic Franchise Growth Led by Regional Developer Drew Myers
As a long-term partner, Corundum Neuroscience will support NeuraWorx as it continues to develop the Cerebrovascular Pacing System by providing access to Corundum Neuroscience's advanced technological projects, scientific expertise and strategic funding.
The upcoming clinical study will be a crucial step in understanding the potential of NeuraWorx's Cerebrovascular Pacing product, paving the way for future advancements in the treatment of central nervous system (CNS) disorders. Both companies are committed to pushing the boundaries of neuroscience to deliver life-changing solutions to improve the lives of patients worldwide. NeuraWorx intends to pursue indications for traumatic brain injury (TBI), Alzheimer's dementia and other CNS disorders, while also developing preventive solutions tailored for military personnel, athletes and a variety of medical applications.
"We are excited to work with Corundum Neuroscience, whose expertise and resources in the neuroscience field will be instrumental in advancing our technology," said Dr. Kip Ludwig, co-founder of NeuraWorx, associate professor at the University of Wisconsin-Madison and co-director of the Wisconsin Institute for Translational Neuroengineering.
"This partnership aligns perfectly with our mission to alleviate suffering and enhance quality of life by developing groundbreaking treatments and preventive solutions for CNS disorders," added Chris Minar, CEO at NeuraWorx.
For more information about NeuraWorx Medical Technologies, Inc., and its innovative approach, visit www.neuraworx.com. To learn more about Corundum Neuroscience and its initiatives, visit www.cnsfund.com.
About NeuraWorx
NeuraWorx Medical Technologies, Inc., is developing a Cerebrovascular Pacing SystemTM, as a first-in-class bioelectronic solution for enhancing cerebral spinal fluid flow and blood flow in the brain. Its products are intended to be for both preventative and therapeutic use, for traumatic brain injury (TBI), Alzheimer's dementia, and other CNS diseases. NeuraWorx was founded in Minnesota, shortly after its science was developed at the University of Wisconsin and the Mayo Clinic. For company updates and information, follow NeuraWorx on LinkedIn or visit: https://www.neuraworx.com
More on TelAve News
- See Our Earth Champions Environmental Education and Conservation Through Initiatives, Dad Hats and Mountain Hats
- NEW AI Launch! StarboxAI VI-Pro - Live Streaming System; Empowering 800 Merchants to Boost Sales to Over 2 Million Users: StarBox (Stock Symbol: STBX)
- El Ranchito Appoints New President
- Mrs Elemental® USA National Competition Introduces the Prestigious Panel of National Judges
- "House of War" Live Event & Podcast Series by Daniel Sadan Debuts This Week
About Corundum Neuroscience
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity, and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023 and is headquartered in Herzliya, Israel.
For company updates and information, follow Corundum Neuroscience on LinkedIn or visit https://cnsfund.com.
Source: NeuraWorx Medical Technologies, Inc.
0 Comments
Latest on TelAve News
- Free Luma Expands Inspiration with Launch of Kids Sizes for Popular RFID Bracelets
- New AI World Record! Startup Zenodelic.ai improves LLMs' understanding of the human mind!
- LCC Asia Pacific Celebrates Milestone with 550th Edition of Engineering & Industrial Services Sector Weekly Research Report
- Brooklyn Artist Allison Eden Studios Creates Presidential Portraits For Auction To Predict Election Results
- Arthur Murray Dance Studio of Denville: Dance Your Way to Joy and Confidence in North Jersey
- Arthur Murray Dance Studio of Napa: Discover the Joy of Dance in Wine Country
- Better Termite & Pest Control Marks 56 Years of Fall Pest Protection
- Halloween Spending Surge Drives U.S. Holiday Economy Growth in 2024
- People are Having Millions of Conversations with Friends and Family About Voting in the 2024 Election
- 5 Questions to Always Ask Roofing Companies in Memphis Before Hiring Them
- Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader: Heartbeam: Stock Symbol: BEAT
- KeysCaribbean Extends Advance Purchase Rate Discount Offer
- Kenneth Carnesi, Sr. COO Anaptyx Honored with 2024 Global Recognition Award
- Mount Dora Craft Fair and Plant Festival set to go on after hurricane hit
- ConverzAI Accelerates Industry Transformation with Groundbreaking AI-Powered Virtual Recruiters
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Significant Leaps Redefining Digital Commerce Connecting Merchants & Shoppers Rewarding Customers with Instant Cash Rebates (Stock Symbol: STBX)
- Michele Vreeland Explores the Supernatural with Haunting New Single 'Soul Collector,' Releasing October 25th, Just in Time for Halloween
- Megabits Per Second (Mbps) Explained: Speed Test For WiFi Shares Essential Insights for Boosting Internet Performance
- Jude Madrigal releases his first children's book, "The Trick-or-Treat Tree and the First Halloween."